Evidence-based Guideline: Diagnosis and Treatment of Limb ...

Oct 12, 2014 · Dr. Barohn has served as a consultant or on a scientific advisory board for Genzyme, Grifols, MedImmune, and Novartis; has received honoraria from Alexion, Isis, Baxter, Sarepta, and CSL Behring; and has received funding for research from the US Food and Drug Administration (FDA) and the NIH. Dr. Ensrud reports no relevant disclosures. ................
................